Composite Meshes: A Comprehensive Review of Materials, Biomechanics, Clinical Outcomes, and Emerging Innovations
Abstract
Hernia repair is among the most frequently performed surgical procedures worldwide. Composite meshes, that is, prostheses incorporating at least two distinct functional layers, were developed to reconcile the competing demands of structural durability and peritoneal biocompatibility. This narrative review synthesizes evidence from peer-reviewed research articles, physicomechanical evaluation studies, and clinical outcome data identified through PubMed, MEDLINE, and Scopus searches spanning 2000-2025. Composite meshes are broadly classified by barrier type as either absorbable or permanent (nonabsorbable). Key physicochemical parameters, namely, pore size, filament diameter, mesh weight, suture retention strength, tear resistance, and anisotropy, significantly influence host tissue integration and clinical performance. Absorbable barrier meshes, including C-QUR (Atrium Medical Corporation, Hudson, New Hampshire, United States), PROCEED (Ethicon, Inc. (a Johnson & Johnson company), Somerville, New Jersey, United States), Parietex Composite (Sofradim Production SAS (a Medtronic company), Trévoux, France), and Bard Sepramesh IP Composite (Davol Inc. (a subsidiary of C.R. Bard, Inc., now Becton, Dickinson and Company), Warwick, Rhode Island, United States), facilitate eventual tissue incorporation after barrier degradation within 30-120 days. Permanent barrier meshes, including DUALMESH (W.L. Gore & Associates, Inc., Flagstaff, Arizona, United States) and Bard Composix E/X and…
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.